Cite
HARVARD Citation
Shah, N. et al. (n.d.). 355 First-in-human phase I study of NKTR-255 in patients with relapsed/refractory hematologic malignancies. Journal for immunotherapy of cancer. pp. A216-A217. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Shah, N. et al. (n.d.). 355 First-in-human phase I study of NKTR-255 in patients with relapsed/refractory hematologic malignancies. Journal for immunotherapy of cancer. pp. A216-A217. [Online].